1. Home
  2. ERO vs EYPT Comparison

ERO vs EYPT Comparison

Compare ERO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ero Copper Corp.

ERO

Ero Copper Corp.

HOLD

Current Price

$25.31

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.02

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERO
EYPT
Founded
2016
1987
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
ERO
EYPT
Price
$25.31
$16.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$25.00
$29.60
AVG Volume (30 Days)
1.0M
1.1M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
696.31
N/A
EPS
1.33
N/A
Revenue
$588,229,000.00
$42,339,000.00
Revenue This Year
$68.14
N/A
Revenue Next Year
$46.45
N/A
P/E Ratio
$18.98
N/A
Revenue Growth
26.74
N/A
52 Week Low
$9.30
$3.91
52 Week High
$26.77
$19.11

Technical Indicators

Market Signals
Indicator
ERO
EYPT
Relative Strength Index (RSI) 62.16 60.28
Support Level $23.60 $15.97
Resistance Level $25.93 $19.11
Average True Range (ATR) 1.14 0.96
MACD 0.06 0.11
Stochastic Oscillator 72.48 46.36

Price Performance

Historical Comparison
ERO
EYPT

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: